SCHEMBL7520140

SCHEMBL7520140

COc1cccc2c1OCC=C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
CYP2B6 P20813 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MAPT P10636 2/20 0.39
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
CA12 O43570 2/20 0.38
CA9 Q16790 2/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA7 P43166 1/20 0.37
CA14 Q9ULX7 1/20 0.37
TP53 P04637 3/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 2/20 0.35
NFE2L2 Q16236 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28445561 0.79 CYP2A6 (0.41) CYP2B6SMN1; SMN2RAB9ATP53LMNA
SCHEMBL28058505 0.79 CYP2B6 (0.33) KMT2ACYP2B6
SCHEMBL28451959 0.78 HTR2C (0.41) KMT2ACYP2B6SMN1; SMN2TP53ALDH1A1
SCHEMBL11192919 0.76 CYP2B6 (0.42) CYP2B6CA9CA1CYP1A1CYP1A2
SCHEMBL12043463 0.76 CYP2B6 (0.42) CYP2B6CA9CA1CA2CA7
SCHEMBL3554338 0.74 HTR7 (0.37) MAPTCA12CA9CA1CA2
SCHEMBL28445449 0.74 CA12 (0.34) KMT2ACYP2B6MAPTCA12CA9
SCHEMBL9112587 0.73 CYP2B6 (0.39) KMT2ACYP2B6SMN1; SMN2NPC1MAPT
SCHEMBL9536321 0.73 ALDH1A1 (0.49) KMT2ACYP2B6SMN1; SMN2MAPTTP53
SCHEMBL28080049 0.72 NFE2L2 (0.30) NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-62063582-A None JP disclosed
CN-111417396-A Methods of treating cancer with small molecule NF-kB inhibitors 免疫目标公司 2020-07-14 CN disclosed
EP-0873993-B1 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2002-02-20 EP disclosed
US-5919814-A Heterocyclic compounds ADIR ET COMPAGNIE (FR) 1999-07-06 US disclosed
EP-0873993-A1 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1998-10-28 EP disclosed
EP-0161218-B1 BENZO-(PYRANO AND THIOPYRANO)PYRIDINES CIBA-GEIGY AG (CH) 1991-06-26 EP disclosed
US-4721787-A CONDENSATION, REDUCTION, DEHYDRATION CIBA-GEIGY CORPORATION (US) 1988-01-26 US disclosed
JP-S6263582-A PRODUCTION OF 3,4-DIHYDRO-3-HYDROXY-8-METHOXY-2H-1-BENZOPYRAN KOWA CO 1987-03-20 JP disclosed
US-4604397-A Certain benzo-(pyrano and thiopyrano)-pyridines, useful as CNS agents CIBA-GEIGY CORPORATION (US) 1986-08-05 US disclosed
EP-0161218-A2 Benzo-(pyrano and thiopyrano)pyridines CIBA-GEIGY AG (CH) 1985-11-13 EP disclosed